MDX-060

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Hodgkin's DiseaseLymphoma, Large-Cell

Phase 2

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

CompletedNCT00284804

Bristol-Myers SquibbHodgkin's Disease

Start: 2005-11-30End: 2009-10-31Updated: 2015-10-12

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

WithdrawnNCT00298467

Bristol-Myers SquibbLymphoma, Large-Cell

Start: 2006-02-28Target: 45Updated: 2010-04-26